Literature DB >> 14731053

Economic evaluation of varicella vaccination programmes: a review of the literature.

Thomas Hammerschmidt, Kurt Banz, Stefan Wagenpfeil, Albrecht Neiss, Peter Wutzler.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 14731053     DOI： 10.2165/00019053-200422020-00005

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  12 in total

1.  A cost benefit analysis of routine varicella vaccination in Spain.

Authors:  J Díez Domingo; M Ridao; J Latour; A Ballester; A Morant
Journal:  Vaccine       Date:  1999-03-17       Impact factor: 3.641

2.  Varicella vaccine and shingles.

Authors:  Marc Brisson; W John Edmunds; Nigel J Gay; Elizabeth Miller
Journal:  JAMA       Date:  2002-05-01       Impact factor: 56.272

3.  THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS.

Authors:  R E HOPE-SIMPSON
Journal:  Proc R Soc Med       Date:  1965-01

Review 4.  Economic evaluations of varicella vaccination programmes: a review of the literature.

Authors:  Nancy Thiry; Philippe Beutels; Pierre Van Damme; Eddy Van Doorslaer
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

5.  Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.

Authors:  Peter Wutzler; Albrecht Neiss; Kurt Banz; Anita Goertz; Helmtrud Bisanz
Journal:  Med Microbiol Immunol       Date:  2002-08-29       Impact factor: 3.402

6.  The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France.

Authors:  L Coudeville; F Paree; T Lebrun; J Sailly
Journal:  Vaccine       Date:  1999-01       Impact factor: 3.641

7.  Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study.

Authors:  Sara L Thomas; Jeremy G Wheeler; Andrew J Hall
Journal:  Lancet       Date:  2002-08-31       Impact factor: 79.321

8.  The cost-effectiveness of routine childhood varicella vaccination in Germany.

Authors:  K Banz; S Wagenpfeil; A Neiss; A Goertz; U Staginnus; J Vollmar; P Wutzler
Journal:  Vaccine       Date:  2003-03-07       Impact factor: 3.641

9.  Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox.

Authors:  M Brisson; N J Gay; W J Edmunds; N J Andrews
Journal:  Vaccine       Date:  2002-06-07       Impact factor: 3.641

10.  Cost-effectiveness of a routine varicella vaccination program for US children.

Authors:  T A Lieu; S L Cochi; S B Black; M E Halloran; H R Shinefield; S J Holmes; M Wharton; A E Washington
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.